Neogen Corp SEC filings NEOG

Neogen Corp has 1,000 filings in SEC EDGAR's recent list, going back to Nov 12, 2013. Its latest annual report, Form ARS, was filed on Aug 21, 2026 for the period ended May 31, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 7, 2026, covering the quarter ended Aug 31, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on May 31.

Form Description Filed Period
ARS Annual report to shareholders Aug 21, 2026 May 31, 2026
10-K Annual report Jul 30, 2026 May 31, 2026
ARS Annual report to shareholders Sep 12, 2025 May 31, 2025
10-K Annual report Jul 30, 2025 May 31, 2025
ARS Annual report to shareholders Sep 13, 2024 May 31, 2024
10-K Annual report Jul 30, 2024 May 31, 2024
ARS Annual report to shareholders Sep 18, 2023 May 31, 2023
10-K Annual report Aug 15, 2023 May 31, 2023
10-K Annual report Jul 27, 2022 May 31, 2022
10-K Annual report Jul 30, 2021 May 31, 2021
10-K Annual report Jul 30, 2020 May 31, 2020
10-K Annual report Jul 30, 2019 May 31, 2019
10-K Annual report Jul 27, 2018 May 31, 2018
10-K Annual report Jul 28, 2017 May 31, 2017
10-K Annual report Jul 29, 2016 May 31, 2016
10-K Annual report Jul 30, 2015 May 31, 2015
10-K Annual report Jul 30, 2014 May 31, 2014

Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Listed as
NEOG (Nasdaq)
Fiscal year ends
May 31
Incorporated in
MI
Headquarters
Lansing, MI
SEC filer status
Large accelerated filer
SEC CIK
711377

Other In Vitro & In Vivo Diagnostic Substances companies

All 21 In Vitro & In Vivo Diagnostic Substances companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.